SW
TXG icon

SVB Wealth’s 10x Genomics TXG Stock Holding History

SVB Wealth’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-429,117
Closed -$3.75M – 1547
2025
Q1 		$3.75M Sell
429,117
-93,492
-18% -$1.18M 0.15% 79
2024
Q4 		$7.5M Buy
+522,609
New +$8.25M 0.14% 101
2024
Q3 		– Sell
-525,044
Closed -$10.2M – 568
2024
Q2 		$10.2M Sell
525,044
-915,516
-64% -$24M 0.25% 98
2024
Q1 		$54.1M Sell
1,440,560
-5,992
-0.4% -$263K 1.21% 11
2023
Q4 		$80.9M Buy
1,446,552
+693,422
+92% +$30.2M 1.97% 7
2023
Q3 		$31.1M Sell
753,130
-94,690
-11% -$4.93M 0.68% 28
2023
Q2 		$47.3M Sell
847,820
-1,424
-0.2% -$77.1K 0.86% 17
2023
Q1 		$47.4M Sell
849,244
-133,573
-14% -$6.24M 0.66% 25
2022
Q4 		$35.8M Sell
982,817
-22,725
-2% -$743K 0.48% 37
2022
Q3 		$28.6M Buy
+1,005,542
New +$38.3M 0.42% 43
2020
Q4 		– Sell
-40,300
Closed -$5.03M – 885
2020
Q3 		$5.03M Sell
40,300
-39,700
-50% -$4.17M 0.08% 146
2020
Q2 		$7.14M Sell
80,000
-60,000
-43% -$4.67M 0.13% 109
2020
Q1 		$8.72M Buy
+140,000
New +$10.9M 0.21% 76

Other funds holding TXG

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SVB Wealth's TXG Position: Q2 2025 in Review

SVB Wealth sold out of 10x Genomics (TXG) in Q2 2025, closing a stake of 429,117 shares — an estimated $3.75M sold.

SVB Wealth first reported a position in TXG in Q1 2020 and held it in 13 quarters. The position peaked at $80.9M in Q4 2023. 297 funds tracked by Wall St. Rank hold TXG as of Q2 2025.

  • SVB Wealth reported no remaining 10x Genomics position as of Q2 2025 after selling out during the quarter.
  • SVB Wealth sold 429,117 10x Genomics shares in Q2 2025, an estimated $3.75M.
  • SVB Wealth first reported a position in 10x Genomics in Q1 2020 and held it in 13 quarters.
  • SVB Wealth's 10x Genomics position peaked at $80.9M in Q4 2023.
  • 297 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2025.

Based on SVB Wealth's 13F filing for Q2 2025, filed 14 Aug 2025.